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Abstract: Hydroxyapatite (HAP) is a widely used biocompatible ceramic in many biomedical 
applications and devices. Currently nanometer-scale forms of HAP are being intensely inves-
tigated due to their close similarity to the inorganic mineral component of the natural bone 
matrix. In this study nano-HAP was prepared via a wet precipitation method using Ca(NO3)2 
and KH2PO4 as the main reactants and NH4OH as the precipitator under ultrasonic irradiation. 
The Ca/P ratio was set at 1.67 and the pH was maintained at 9 during the synthesis process. The 
influence of the thermal treatment was investigated by using two thermal treatment processes 
to produce ultrafine nano-HAP powders. In the first heat treatment, a conventional radiant tube 
furnace was used to produce nano-particles with an average size of approximately 30 nm in 
diameter, while the second thermal treatment used a microwave-based technique to produce 
particles with an average diameter of 36 nm. The crystalline structure and morphology of all 
nanoparticle powders produced were investigated using X-ray diffraction (XRD), field emission 
scanning electron microscopy (FESEM), transmission electron microscopy (TEM), and Fourier 
transform infrared spectroscopy (FT-IR). Both thermal techniques effectively produced ultrafine 
powders with similar crystalline structure, morphology and particle sizes.
Keywords: nano-hydroxyapatite, chemical synthesis, ultrasonic irradiation, microwave 
irradiation
Introduction
The skeletal system is vital for the support and locomotion of the human body; it is 
constructed of cartilaginous materials and a hard natural tissue; bone. Bone is a complex 
organic–inorganic ceramic composite consisting of organic collagen fibrils containing 
well-arrayed embedded inorganic nano-crystalline rod- and plate-like materials rang-
ing in size from 25 to 50 nm in length.1,2 Naturally occurring hydroxyapatite (HAP) is 
a mineral with a hexagonal structure that is composed of calcium phosphate groups 
with a general formula of Ca10(OH)2(PO4)6 for the unit cell. Both crystallographic and 
chemical studies have shown that synthetic HAP is similar to the natural occurring 
inorganic component found in the bone matrix and teeth. Because of this close simi-
larity there has been an extensive research effort to employ synthetic HAP as a bone 
substitute and/or replacement in several biomedical applications.3,4
There are several significant advantages in using synthetic HAP in hard tissue 
engineering applications; it has good biocompatibility and bioactivity properties with 
respect to bone cells and other body tissues, a slow biodegradability in situ and it also 
offers good osteoconductivity and osteoinductivity capabilities.5–7 These properties 
are very important because bone tissue constantly undergoes remodelling, a process 
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whereby bone tissue is simultaneously replaced and removed 
by the bone cells, (osteoblasts and osteoclasts, respectively). 
An investigation by Taniguchi et al has shown that sintered 
HAP exhibited an excellent biocompatible response to soft 
tissue such as skin, muscle, and gums.8 It is this type of 
response that has made synthetic HAP an ideal candidate for 
orthopedic and dental implants. Current hard tissue engineer-
ing applications include bone repair, bone augmentation, 
coating of metal implants, and as filler material for both 
bone and teeth.9–11 Unfortunately, due to its low mechanical 
strength, the use of pure HAP ceramics is restricted to low 
load bearing clinical applications. In some cases, combining 
HAP with other materials, such as polymers and/or glasses to 
form a composite, can alleviate these deficiencies. Materials 
such as high-density polyethylene and polypropylene can be 
used to improve the load-bearing capabilities of HAP.12,13
In addition, the complex structure of HAP has the added 
advantage of providing a very good absorption matrix for a 
variety of pharmaceutical products such as antibiotics, drugs, 
enzymes, hormones, and steroids. Both HAP-antibiotic and 
HAP-drug composites have been successfully used for the 
slow release of pharmaceutical products in situ.14–16 This 
type of drug delivery platform has proven to be effective in 
the treatment of diseases such as osteomyelitis, osteoporosis 
and osseous cancer, where the slow and sustained release of 
pharmaceuticals such as antibiotics has enhanced recovery 
from the disease.17
Recent and continuing research in nanotechnology and 
  tissue engineering has highlighted the need to investigate 
the formation of HAP in the nanometer size range and 
clearly define its properties at this scale. This is essential in 
nanotechnology, because matter at the nanometer scale can 
have significantly different physicochemical properties.18–21 
  Significant improvements in the properties of HAP can be seen 
when the material is synthesized in the nanoscale range.22–25 
For example, in a HAP particle study conducted by Sun et al 
on the influence of particle size on in vivo osteoblast cells, it 
was discovered that the inflammatory response was inhibited 
when smaller particle sizes (0.5–3.0 µm) were used.22 Cells are 
generally in the micron-size range; however, their component 
structures and associated environment are in the nanometer 
to sub-micron range. In fact, the molecular building blocks of 
life: proteins, carbohydrates, nucleic acids, and lipids are all 
nanoscale structures. It is the crucial interaction between the 
cell and nanostructures such as proteins that is responsible for 
controlling cell functions such as proliferation, migration, and 
the production of the extracellular matrix. Importantly, it is 
the physical structure and chemistry of the nanostructure that 
directly influences the behaviour of the cell in contact with the 
surface. For example, the cell-substrate interaction is highly 
dependent on the nature of surface properties such as surface 
charge, surface chemistry,26 wettability,27 surface density 
of cell-binding ligands,28 and nanotopography.29,30 A major 
function of tissue engineering is to create an environment that 
can promote productive and efficient cellular activity. This 
is where nanotechnology has a significant role to play, since 
it permits the individualized creation of a scaffold structure 
that can be maximized for optimal environmental conditions 
specific to bone cells. Therefore, for any meaningful devel-
opment in the future therapeutic use of nano-hydroxyapatite 
(nano-HAP)-based scaffold structures in the medical field, 
efficient manufacturing techniques are needed to produce 
large quantities of nano-HAP with well-defined chemical 
and physical properties.
Historically, several techniques were developed and 
have been used to manufacture HAP and calcium phosphate 
ceramics. These diverse techniques include homogeneous 
precipitation,31,32 sol-gel,33 plasma spray,34 hydrothermal,35 
and ultrasonic spray freeze drying processes.36 The most 
attractive technique mentioned above is the sol-gel   process. 
This wet chemical method is based on a simple and straight-
forward procedure that can economically produce HAP 
without the need for expensive specialized equipment. 
Moreover, this technique can be easily scaled up to meet 
high demands. However, the main difficulty encountered in 
using this technique is being able to effectively control the 
size and morphology of the resulting nanoparticles to within 
a specific parameter range. The fine-tuning of both size and 
morphology is crucial in determining the properties of the 
resulting nano-HAP powders.
Wet chemical techniques can produce crystalline mate-
rials from solutions, but a subsequent thermal treatment 
at   elevated temperatures is required to produce specific 
crystalline phases. The particle size and morphology of 
HAP   produced using this technique can be controlled by 
varying the experimental conditions that regulate nucleation, 
the aging process, and the growth kinetics of the particles. The 
controlling parameters that are used to produce monophase 
HAP are the initial reactants, the preparation temperature, 
and the pH value. Using a wet chemical method, Khopade 
et al37 and An et al38 were able to produce HAP particles that 
had a plate-like structure or morphology, in stark contrast to 
the spherical HAP particles produced under the influence of 
ultrasonic irradiation.
The precipitation method is the most commonly used 
wet chemical technique for producing either homogeneous 
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or inhomogeneous calcium phosphate ceramics.39 It should 
also be mentioned that the electronic properties of HAP are 
sensitive to several variables such as Ca/P ratios, structural 
defects, crystal size, temperature, and the preparation pro-
cedures used to produce the HAP.40 Several chemical routes 
have been used to manufacture HAP with diverse results; the 
deviation from the normal HAP phase can be significant and 
is technique dependent.41 In addition, the presence of other 
molecules in the synthesis process can influence the type of 
HAP phase produced. This influencing effect has been used 
by Wang et al to create a molecular template for producing 
HAP nanorods.42
The properties of nanocrystalline HAP produced using 
a hydrothermal process was investigated by Guo and Xiao, 
whose study revealed that particle size decreased as the 
thermal treatment temperature increased.43 A similar study by 
Meissner et al indicated that the size and morphology of the 
synthesized HAP could be controlled and that both size and 
morphology were dependent on the precipitation temperature 
and the ultrasound power used.44 The relationship between 
particle size and temperature was also investigated by 
Laquerriere et al who were able to demonstrate particle size 
reduction with increasing thermal treatment temperatures.45 
The dependence of ultrasonic irradiation on both particle size 
and morphology was investigated and confirmed by Li-Yun 
et al when they were able to produce a monophase nano-HAP 
material using a 300 W ultrasound transducer.46
The wet milling process is an important procedure carried 
out during sample preparation. The use of ultrasonic irradia-
tion during wet milling is an efficient means of dispersing and 
de-agglomerating the sample particles during the grinding 
process. The sonochemical effects which produce acoustic 
cavitations, promote both chemical reactions and physical 
effects that directly influence particle morphology during the 
growth phase. The major advantages of using ultrasonic irra-
diation during the manufacture of superfine particle   slurries 
are: (1) increased reaction speed, (2) decreased processing 
time, and (3) an overall improvement in the efficient use of 
energy.47 In previous chemical precipitation techniques, the 
authors investigated several reactants with varying degrees of 
success in controlling the particle size and morphology. In this 
paper, we study a recently developed chemical route that uses 
calcium nitrate tetrahydrate (Ca[NO3]2 ⋅ 4H2O) and potassium 
dihydrogen phosphate (KH2PO4) as the main reactant materials. 
The control of the pH during the synthesis process was achieved 
by the addition of ammonium hydroxide (NH4OH).48
This paper also undertakes to examine the thermal influ-
ence of two thermal treatment techniques used in the   formation 
of nano-HAP from the precursor nuclide formed in the wet 
synthesis process. The first thermal technique uses a con-
ventional tube furnace while the second uses a microwave 
oven. Microwave heating differs significantly from the heat-
ing mechanism that occurs in a conventional furnace. In the 
furnace, energy travels through the material, via the thermal 
conduction of heat from the surface towards the centre of the 
material. This type of heating process produces a large thermal 
gradient from the surface to the centre of the material. In par-
ticular, if the material is a poor thermal conductor the thermal 
gradient can be quite high. The advantage of using microwave 
heating arises from the way the energy is volumetrically intro-
duced throughout the material; this is fundamentally different 
to the thermal conduction mechanism that occurs in a radiant 
conventional furnace.49,50
Materials and methods
Materials
HAP powders were synthesized from calcium nitrate tet-
rahydrate (Ca[NO3]2 ⋅ 4H 2O) and potassium di-hydrogen 
phosphate (KH2PO4) as the main reactant materials. The 
pH control of the solutions was achieved by the addition 
of ammonium hydroxide (NH4OH). All analytical grade 
reagents used in this work were supplied by Chem-Supply 
Pty Ltd (Gillman, South Australia, Australia). The ultrasound 
processor was an UP50H (50 W, 30 kHz, MS7 Sonotrode 
(7 mm diameter, 80 mm length)) supplied by Hielscher 
Ultrasound Technology (Teltow, Germany). All solutions 
were made using Milli-Q® water (18.3 MΩ cm−1; Millipore 
Corporation, Billerica, MA).
Methods
Synthesis of initial nano-hAP crystallites
The synthesis of nano-HAP was begun by placing a 40 mL 
solution of 0.32M Ca(NO3)2 ⋅ 4H2O into a small beaker. The 
solution pH was then adjusted to 9.0 with approximately 
2.5 mL ammonium hydroxide. The solution was then exposed 
to ultrasonic irradiation, with the processor set at maximum 
amplitude for 1 hour. At the end of the first hour a 60 mL 
solution of 0.19M [KH2PO4] was then slowly added drop-
wise into the first solution while undergoing a second hour 
of ultrasonic irradiation. During the mixing process, the pH 
value was checked and maintained at 9 while the Ca/P ratio 
was maintained at 1.67. The solution was then filtered using 
centrifugation (~2000 g), after which the resultant white 
precipitate was proportioned into a number of samples for 
heat treatment. There were two sample sets made, the first 
consisting of twelve samples for thermal treatment in the 
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tube furnace and the second consisting of five samples for 
microwave treatment.
Thermal treatment process
The two thermal treatment processes used to investigate the 
thermal influence in the formation of nano-HAP powders were 
a conventional electric tube furnace and a standard domestic 
microwave oven. In the case of the electric tube furnace, the 
white precipitate samples were placed into ceramic boats 
before being positioned in the furnace for thermal treatment. 
During treatment, the reaction temperatures varied between 
samples and ranged from 100°C to 400°C over specific time 
periods. For example, samples heated at 100°C required a 
12-hour treatment period, while samples heated at tempera-
tures of 200°C, 300°C, and 400°C had a 2-hour period. The 
longer reaction time for the 100°C samples was necessary to 
produce both crystalline and harder nano-HAP powders. This 
was necessary because earlier studies with shorter thermal 
treatment periods had produced nano-HAP powders with a 
consistent soft, mixed crystalline and amorphous structure. 
A total of twelve samples were treated, each sample matched 
a respective power setting of the ultrasound processor and 
thermal reaction temperature used (see Table 1). The second 
thermal treatment process used a standard domestic house-
hold microwave (1100 W at 2450 MHz; LG®, Eastern Creek, 
New South Wales,   Australia). The five precipitate samples 
were each placed into a fused silica crucible, which was 
supplied by Rojan Advanced Ceramics Pty Ltd (Henderson, 
Western Australia, Australia). Then in turn, each crucible with 
sample was placed into the microwave for thermal treatment. 
A 40-minute treatment period was used for all samples, 
with each sample matched to a   respective percentage power 
Table  1  Furnace  thermal  treatment  at  different  times  and 
ultrasound power used during the synthesis process
Sample Ultrasound power 
(%) (Maximum  
amplitude)
Thermal  
treatment  
temperature (°C)
Treatment   
duration  
(hours)
S-1 100 100 12
S-2 100 200 2
S-3 100 300 2
S-4 100 400 2
S-5 50 100 12
S-6 50 200 2
S-7 50 300 2
S-8 50 400 2
S-I 0 100 12
S-II 0 200 2
S-III 0 300 2
S-IV 0 400 2
Table  2  Nano-hAP  particle  sizes  obtained  from  XRD  and 
FESEM  in  terms  of  ultrasound  power  and  thermal  treatment 
temperature
Particle size (nm ± 5%) Temperature
Technique Ultrasound  
power (W)
100°C 200°C 300°C 400°C
XRD 0 230 230 230 180
25 88 44 36 32
50 58 35 30 25
FESEM 0 150 140 170 130
25 72 60 43 36
50 48 40 28 26
Abbreviations: HAP, hydroxyapatite; XRD, X-ray diffraction; FESEM, field emission 
scanning electron microscopy.
setting (see Table 3). The general processing procedure and 
the respective thermal treatments are schematically presented 
in Figure 1.
Characterization
At the end of each thermal treatment the sample ended up 
as a white agglomerated mass. Once cooled, the material 
was milled to form a fine powder, which was subsequently 
characterized using X-ray diffraction spectroscopy (XRD), 
Field Emission Scanning Electron Microscopy (FESEM), 
Transmission Electron Microscopy (TEM), and Fourier 
Transform Infrared (FT-IR) techniques. Powder XRD 
spectra were recorded at room temperature, using a Siemens 
D500 series diffractometer (Siemens, Munich, Germany), 
(Cu Kα = 1.5406 Å radiation source) operating at 40 kV 
and 30 mA. The diffraction patterns were collected over a 
2θ range from 20° to 60° with an incremental step size of 
0.04° using flat plane geometry. The acquisition time was 
2 seconds. The powder XRD spectrum was used to identify 
the purity of the final nano-HAP powders and any other 
phases that were present. The crystalline size of the particles 
in the powders was calculated using the Debye–Scherrer 
equation (Equation 1) from the respective XRD patterns and 
estimated from the corresponding FESEM micrographs.
The morphological and macrostructural features of the 
nano-HAP powders were investigated using FESEM. All 
micrographs were taken using a high resolution FESEM (Zeiss 
1555 VP-FESEM; Carl Zeiss AG, Oberkochen, Germany) 
at 3 kV with a 30 µm aperture operating under a pressure of 
1 × 10−10 Torr. FT-IR spectroscopy investigations were carried 
out using a Bruker Optics IFS 66 series FT-IR spectrometer 
(Bruker Optik Gmbh, Ettlingen, Germany). The KBr   pellet 
technique was used, in which 2 g of nano-HAP powder was 
mixed with 5–10 g of spectroscopic grade KBr and then 
compressed at around 15 kPa to form a disk. In addition, the 
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40 mL
0.32 M Ca(NO3)2 Ca(NO3)2 and NH4OH
mixed and ultrasound
(0 W, 25 W, and 50 W)
time = 1 hour
White precipitate formed
 ultrasound (0 W, 25 W, and 50 W)
time = 1 hour
White precipitate filtered
Microwave oven
Thermal treatment
process
Tube furnace
100°C, 200°C,
300°C, 400°C
60 mL
0.19 M KH2PO4
2.5 mL
NH4OH
Figure 1 Schematic of experimental procedure for synthesizing nano-hAP.
Table  3  Nano-hAP  particle  sizes  produced  with  respect  to 
microwave power setting
Sample Microwave  
power (%)
Mean particle  
size (nm ± 5%)
M-1 20 37
M-2 40 37
M-3 60 36
M-4 80 35
M-5 100 35
Note: Samples prepared using an ultrasound power of 50 W.
Abbreviation: hAP, hydroxyapatite.
FESEM micrographs were also used to estimate the nano-HAP 
particle size by graphically measuring the size of each particle. 
The particle size of every particle in a 500 nm square grid was 
measured and then the mean particle size was determined from 
the data. All FT-IR spectra data was recorded in the range 
from 400 cm−1 to 4000 cm−1 in steps of 4 cm−1. The resulting 
spectra were then analyzed using the OMNIC® software pack-
age (Thermo Fisher Scientific, Waltham, MA).
In addition, each sample thermally treated using the 
microwave technique was also examined using TEM. This 
technique was used to elucidate the formation of spherical 
crystalline agglomerations formed under the influence of the 
microwave-induced thermal treatment. Prior to TEM exami-
nation, the sample nano-HAP powder was dispersed in ethyl 
alcohol using a low-powered sonic bath. Once   thoroughly 
dispersed, a drop of the suspension was deposited onto a 
  carbon-coated copper TEM grid using a micro pipette and 
then allowed to slowly dry over a 24-hour period. After sam-
ple preparation a bright field TEM study was carried out using 
a Phillips CM-100 electron microscope (Philips   Corporation, 
Eindhoven, the Netherlands) operating at 80 kV .
Results
X-ray diffraction spectroscopy
The crystalline phases of all samples were found to be con-
sistent with phases incorporated in the ICDD (International 
Centre for Diffraction Data) databases. The XRD patterns for 
all 12 samples thermally treated in the tube furnace at different 
treatment temperatures (as detailed in Table 1) are presented 
in Figure 2. Figure 2A presents the XRD patterns of samples 
(S-I to S-IV) that were synthesized without the assistance of 
ultrasonic irradiation. In contrast, Figure 2B presents the XRD 
patterns of samples (S-1 to S-8) that were synthesized in the 
presence of ultrasonic irradiation. The main (h k l) indices for 
HAP are: (0 0 2), (2 1 1), (1 1 2), (3 0 0), (2 0 2), (1 3 0), (2 
2 2), (2 1 3), and (0 0 4) and are included in Figure 2A and 
B to assist in the identification of the peaks.
The XRD patterns of samples S-I to S-IV in Figure 2A (no 
ultrasonic irradiation) show peaks with significant intensities 
in the 2θ range 23.4°–23.7°, 26.9°–27.4°, and a much lower 
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Figure 2 XRD patterns for nano-hAP powders prepared under different experimental conditions as listed in Table 1. Notes: (A) No ultrasound: Samples S-I to S-IV,   
(B) Ultrasound: Samples S-1 to S-8.
Abbreviations: XRD, X-ray diffraction; hAP, hydroxyapatite.
intensity peak at 40.4°–40.9°. These peaks are consistent with 
the CaH2P2O7 phase (International Center for Diffraction Data, 
Joint Committee on Powder Diffraction Standards, CPDS 
No 41-0487). In addition, the intensities of these peaks are 
noticeably reduced in the sample thermally treated at 400°C, 
which suggests that there is an impurity phase present in this 
predominately nano-HAP material. The XRD patterns of 
samples S-1 to S-8 in Figure 2B (ultrasonically irradiated) 
show peaks with a significant reduction in the intensities for 
the 2θ range 23.4°–23.7° when compared to similar peaks in 
Figure 2A. There was very little change in peak intensity for 
samples S-4 (100% ultrasound power) and S-8 (50% ultra-
sound power) for the 400°C treatment temperature. Also, the 
intensity of peaks found in the XRD patterns in the 2θ range 
26.9°–27.4° for samples S-1 and S-5 (100°C), and S-2 and S-6 
(200°C) shows significant enhancement. The intensity ratios of 
these peaks when compared to those found in the 23.4°–23.7° 
range, do not exactly match the CaH2P2O7 phase. The known 
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calcium hydrogen phosphate phases, such as CaH4(PO3)2 ⋅ H2O 
(JCPDS 46-0494), do not appear to be the impurity phases; 
since this would alter the intensity ratio of the (0 0 2) and (2 
1 1) indexed HAP peaks significantly. A greatly reduced cal-
cium dihydrogen diphosphate (CaH2P2O7) phase, and possibly 
diammonium hydrogen phosphate, (NH4)2HPO4 (Acta Crystal-
lographica B28 [1972] 2065-2069) phase, seems to be present 
in the predominately HAP phase for samples thermally treated 
at 100°C and 200°C. The (CaH2P2O7) phase is a member of 
the crystalline and amorphous calcium phosphate family that 
often forms during the thermal treatment of HAP.51
The XRD patterns of samples (M-1 to M-5) thermally 
treated in the microwave oven are presented in Figure 3. 
All samples were synthesized in the presence of ultrasonic 
irradiation (50 W power setting) before being placed into 
the microwave for thermal treatment. A 40 min treatment 
period was used for all samples, with each sample being 
matched to a respective power setting (see Table 3). All 
sample XRD patterns revealed the presence of crystalline 
nano-HAP phases. These phases were found to be consis-
tent with phases listed in the ICDD database, with the main 
(h k l) indices for nano-HAP: (0 0 2), (2 1 1), (1 1 2), (3 0 0), 
(2 0 2), (3 1 0), (2 2 2), (2 1 3), and (0 0 4)  being indicated 
in Figure 3. The patterns reveal significant peak intensities 
in the 2θ range between 26.9° and 27.4°, which indicate the 
presence of the (CaH2P2O7) phase (JCPDS No 41-0487). 
Inspection of Figure 3 reveals that the peak intensities were 
generally reduced by increasing the microwave power, (from 
20% to 100%) whilst the nano-HAP peak at (002) steadily 
increased in intensity over this range. This thermal effect 
transformed the impure calcium apatite precursor phase 
into the pure nano-HAP phase. Comparing XRD patterns 
of samples S-4 and S-8, both thermally treated in the tube 
furnace at 400°C, with sample M-5 that was thermally 
treated at 100% microwave power, we can see a remarkable 
resemblance between the XRD patterns.
The crystallite size, t(hkl), of the synthesized nano-HAP 
powders was calculated from the XRD pattern using the 
Debye–Scherrer equation.52–54
  t
B
hkl
hkl
()
()
.
cos
=
09 λ
θ
 
(1)
where, λ is the wavelength of the monochromatic X-ray beam, 
B is the Full Width at Half Maximum (FWHM) of the peak 
at the maximum intensity, θ(hkl) is the peak diffraction angle 
that satisfies Bragg’s law for the (h k l) plane, and t(hkl) is the 
crystallite size.
The (0 0 2) reflection peak from the XRD pattern was used 
to calculate the average nano-HAP crystallite size from the 
Debye–Scherrer equation. The calculation was done so that 
a comparison could be made of the products produced by 
the various thermal treatment temperatures. The calculated 
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Figure 3 XRD patterns of nano-hAP powders prepared in the presence of 100% Ultrasound power and thermally treated in a microwave oven at various power settings.
Abbreviations: XRD, X-ray diffraction; hAP, hydroxyapatite.
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Figure 4 FESEM images of nano-hAP powder samples at various thermal treatment 
temperatures (scale bars shown in each image). (i) No ultrasound in preparation 
(A)  300°C  and  (B)  400°C  (ii)  Ultrasound  used  in  preparation  (C)  300°C  and 
(D) 400°C.
Abbreviations:  FESEM,  field  emission  scanning  electron  microscopy;  HAP, 
hydroxyapatite.
Figure  5  FESEM  images  of  nano-hAP  powder  samples  thermally  treated  in 
a  microwave  oven  at  various  power  settings  (A)  20%,  (B)  60%,  (C)  80%,  and   
(D) 100% (scale bars shown in each image).
Abbreviations:  FESEM,  field  emission  scanning  electron  microscopy;  HAP, 
hydroxyapatite.
100 nm
105 K 9258
Figure  6  TEM  micrograph  of  spherical  crystalline  agglomerations  produced  by 
microwave induced thermal treatment of nano-hAP powders.
Abbreviations: TEM, transmission electron microscopy; hAP, hydroxyapatite.
crystallite sizes for samples thermally treated in the tube 
furnace are presented in Table 2, while the sizes for samples 
treated in the microwave are presented in Table 3.
Field emission scanning electron 
microscopy and transmission electron 
microscopy examination of samples
The FESEM microscopy technique was used to investi-
gate the size and morphology of the nano-HAP powders 
produced in both cases. Figure 4 presents typical FESEM 
images of nano-HAP powders thermally treated in the tube 
furnace. The powders presented in Figure 4A and B were 
produced without ultrasound, while Figure 4C and D were 
synthesized in the presence of ultrasound. Inspection of all 
images reveals the presence of spherical particle morphol-
ogy in all samples produced, this is similar to the particle 
morphologies reported in the literature.39,55–59 The mean 
particle sizes determined from the FESEM images are 
tabulated in Table 2. These particle sizes compare favorably 
with those calculated from the XRD spectra. At the lower 
temperatures of 100°C and 200°C, the particle sizes show 
greater variation, (17.2% at 100°C and 14.3% at 200°C) but 
at the higher temperatures the two techniques tend to give 
smaller particle sizes with decreasing variation (6.7% at 
300°C and 4.0% at 400°C). This appears to be the influence 
of the shape and orientation of the particles being imaged in 
the FESEM compared to the sizes calculated from the XRD 
technique. At higher temperatures the thermal treatment 
produces a more uniform particle shape, orientation, and 
regularity; hence both FESEM and XRD techniques pro-
duce more consistent particle size data.   Figure 5   presents 
a selection of FESEM images of   nano-HAP powders 
thermally treated in the microwave oven at various power 
settings. All four images reveal the spherical morphology 
of the particles; they are highly agglomerated and have a 
mean size of around 36 nm (Table 3). A TEM study was 
undertaken to further investigate the spherical nature of the 
particles and agglomerating characteristic of the   powders. 
A typical TEM micrograph of a nano-HAP powder ther-
mally treated using a microwave oven at 100% power 
is presented in Figure 6. The micrograph confirms the 
spherical geometry of the particles and their agglomerat-
ing nature. The micrograph also confirms the size range 
of the particles (26–43 nm), with the mean particle size 
estimated to be 36 nm.
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Fourier transform infrared  
examination of samples
The thermal influence in the formation of nano-HAP of both 
the tube furnace and the microwave oven were investigated. 
Both thermal processes produce similar spectra, which con-
firm the presence of nano-HAP in the synthesized powders. 
Figure 7 presents a typical spectrum of nano-HAP powders 
thermally treated in the tube furnace, while Figure 8 shows 
the results of the thermal treatment performed in a micro-
wave oven at five specific power settings. The FT-IR analysis 
was carried out to identify species, functional groups, and 
vibration modes associated with each peak. The following 
analysis was common to all samples thermally treated and 
was used to identify the presence of nano-HAP. To begin 
with, the bands occurring at 564 cm−1 and 601 cm−1 are the 
result of ν4 vibrations of the O-P-O mode. The two weaker 
peaks located at 725 cm−1 and 832 cm−1 are associated with 
the carbonate group and clearly indicate the presence of 
carbonates in the samples. The band located at 961 cm−1 is 
produced by the ν1 symmetric stretching vibrations of the 
P-O mode. The very strong peaks located at 1032 cm−1 and 
1092 cm−1 correspond to the PO4
3− functional group, and the 
weaker peak at 1384 cm−1 corresponds to the CO3
2− functional 
group. The presence of the carbonate ion results from the 
interaction between atmospheric carbon dioxide and the 
nano-HAP precursor alkaline solution sample, this reaction 
has been seen in other studies.60–62 The smaller peak located 
at 1644 cm−1 also corresponds to a CO3
2− group. The band 
located at 3432 cm−1 indicates the presence of absorbed water 
and the weak peak located at 3570 cm−1 corresponds to the 
vibrations of OH− ions in the nano-HAP lattice. This analysis 
indicates that both thermal treatment techniques produced 
nano-HAP powders of high quality.
Discussion
The XRD results for samples thermally treated in the tube 
furnace clearly indicate that the use of ultrasonic irradiation 
during the synthesis process has influenced the chemical 
interactions between the reacting species. This influence is 
believed to alter the rate of formation and chemical equilib-
rium of the calcium hydrogen phosphate phases. The results 
also revealed the presence of another chemical species, 
probably a form of calcium hydrogen phosphate, which was 
formed in significant amounts in samples thermally treated at 
100°C and 200°C. At higher thermal treatment temperatures 
such as 400°C there were insignificant amounts formed. 
Also, a close inspection of the XRD patterns presented in 
Figure 2 reveals that the (0 0 2) nano-HAP diffraction peak 
intensity remained fairly constant, but its width broadens as 
the thermal treatment temperature increases. Li-Yun et al 
has reported a slight decrease in the (0 0 2) nano-HAP peak 
intensity and explained that it was the result of a change in 
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Figure 7 A typical FT-IR spectrum of a nano-hAP powder thermally treated in the tube furnace.
Abbreviations: FT-IR, Fourier transform infrared; hAP, hydroxyapatite.
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the shape of the nano-HAP particles (acicular vs spherical).46 
In this study, the (0 0 2) peak results indicate the presence of a 
particular particle shape common to all samples. Subsequent 
FESEM and TEM images confirm the presence of spherical 
particle geometry in all samples. Another interesting fea-
ture of the thermal treatment carried out in the tube furnace 
is the decrease in particle size with increasing treatment 
  temperature. Furthermore, as the ultrasound power used 
in the synthesis process increases, the particle sizes of the 
nano-HAP crystallites decreases (see Table 2).
The second type of thermal influence investigated was 
the effect of microwave heating on nano-HAP particle 
formation. The (0 0 2) reflection peak from the microwave 
XRD patterns (Figure 3) was used to calculate the average 
nano-HAP crystallite size from equation 1. The calculated 
particle sizes for samples M-1 to M-5 are presented in 
Table 3. The most striking difference between the two ther-
mal treatments is the size range of the resulting nano-HAP 
crystallites. In the tube furnace, the particle size decreased 
with the increasing thermal treatment temperature, but in 
the case of the microwave oven treatment, the particle size 
remained relatively consistent across all power settings with 
a mean value of 36 nm. This value is similar to the particle 
size obtained by Siddharthan et al using a microwave-based 
thermal treatment process.50
The presence of ultrasound in the synthesis procedure 
prior to the thermal treatment has a significant influence in 
forming the initial nano-HAP particle precursors. This is due 
to the particle size being related to nucleation and the growth 
pattern of the material, which in turn is related to the degree 
of super saturation within the liquid phase. The presence of 
ultrasonic irradiation in the synthesis process formed bubbles 
that grew and then implosively collapsed creating localized 
hot spots. These localised hot spots can reach temperatures of 
up to 5300 K and pressures around 500 atmospheres, which 
are then followed by rapid cooling rates often exceeding 
1010 K/s.61 These extreme pressure and temperature varia-
tions promote both physical effects and chemical reactions 
that directly influence the synthesis of materials in the liquid 
phase.62 In addition, both the particle size and its morphology 
can be directly influenced during this synthesis process. The 
effect of increasing the ultrasound power from 0 to 50 W 
showed that it was possible to decrease the particle size prior 
to thermal treatment (see Table 2). The increasing ultrasound 
power used to irradiate the liquid indicated that greater num-
bers of bubbles/cavitations were being produced. This in turn 
produced more nucleation sites and as a result the particles 
formed around these sites are smaller. Furthermore, particles 
exposed to longer periods of ultrasonic irradiation show less 
agglomeration. Subsequent FESEM data has confirmed the 
reduced particle agglomeration when ultrasound is used 
during the synthesis process.
It is interesting to note that both thermal treatments 
produce nano-HAP particles that are spherical in nature and 
highly agglomerated. These characteristics have been con-
firmed by both FESEM images and TEM micrographs. The 
FESEM images of all nano-HAP powders were examined 
and then the mean particle size was determined. In the case 
of the tube furnace thermal treatment, there was a definite 
trend in the mean particle size decreasing with increasing 
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treatment temperature. The FESEM results confirmed the 
same trend seen in the XRD analysis. The FESEM image 
analysis also confirmed that mean particle size decreased 
when the ultrasound power increased during the synthesis 
process (see Table 2). The FESEM images taken of particles 
synthesized in the presence of ultrasound and thermally 
treated in the microwave had a different size characteristic. 
In fact the mean particle size remained fairly constant across 
all power settings (see Table 3).
The results of the FT-IR analysis indicate that both ther-
mal techniques have produced nano-HAP powders of high 
quality. The influence of microwave power on the thermal 
treatment process can be seen in Figure 8. Inspection of 
  Figure 8 reveals some important differences in the spectra 
for each power setting, with the 20% power setting producing 
the most significant differences. Moving from left to right 
across Figure 8, we can see that the percentage transmittance 
in the range from 2400 to 3750 cm−1 for all power settings 
except the 20% is reasonably close. The larger transmittance 
for the 20% power setting is the result of a larger presence 
of absorbed water and the weak peak located at 3570 cm−1 
corresponds to the vibrations of OH− ions in the nano-HAP 
lattice. The peaks located at 1644 cm−1 and 1384 cm−1 indi-
cate the presence of the CO2−
3 function groups and we can 
see that 20% power setting has the largest presence of the 
CO2−
3 group while the 100% power setting has the lowest 
presence. The decrease in peak amplitude with increasing 
power suggests that during the thermal treatment the CO2–
3 
group is being incorporated into the forming nano-HAP. The 
peaks located at 1032 cm−1 and 1092 cm−1, which correspond 
to the PO4
3− functional group, are noteworthy because both 
the 20% and 100% power setting are similar in amplitude. 
The remaining power settings have lower transmittance 
values. The peaks located at 725 cm−1 and 832 cm−1 are also 
associated with the carbonate group and tend to decrease 
with increasing power. The peaks located at 564 cm−1 and 
601 cm−1, which result from the ν4 vibrations of the O-P-O 
mode, are also affected by the increasing power. The lower 
20% power setting produced the greatest difference in 
transmittance, while the higher power settings all produced 
similar transmittance values.
The FT-IR analysis reveals that increasing the microwave 
power from 20% to higher settings significantly changes 
peak amplitudes. In the case of the 1384 cm−1 peak the 
higher powers all have similar transmittance, while at the 
1032 cm−1 peak the 40% and 80% power settings have simi-
lar transmittance values. The 60% and 100% power settings 
have high transmittances, but are still lower than the 20% 
power setting. The changes in peak intensities indicate the 
transformation of an impure calcium apatite phase into the 
pure nano-HAP phase. This transformation was also seen in 
the XRD analysis.
This study has shown that there is a significant thermal 
and ultrasonic influence in forming nano-HAP. In terms of 
throughput, the combined ultrasound/microwave technique is 
superior to the conventional tube furnace for producing nano-
HAP ultrafine powders. The technique used clearly demon-
strates an economic route with a strong scale-up   capability. 
An interesting feature of the ultrasound/  microwave technique 
is that the particle size is fairly consistent across all power 
settings, which indicates that the current technique can only 
produce a mean particle size of 36 nm. On the other hand, the 
thermal treatment performed in the tube furnace gave greater 
temperature control and produced temperature dependent 
particles sizes. The higher the thermal treatment temperature 
used, the smaller the particle size produced. It is interesting 
to note that the different heating effect produced by the 
microwave oven does not show any particle size dependence. 
Even when using a different microwave power setting each 
time over a fixed operating period (40 minutes) little effect 
was observed on the particle size. The exact mechanism that 
is occurring during the microwave thermal treatment needs 
to be further investigated.
Conclusion
Hydroxyapatite is a ceramic that is generally considered to be 
a viable substitute for bone material in many clinical biomedi-
cal and tissue engineering applications. In this study, the influ-
ence of ultrasound in the synthesis of nano-HAP powders was 
examined in conjunction with the type of thermal treatment 
used. Nano-HAP particles in the nanometer size range and 
spherical morphology were produced using a wet chemical 
precipitation technique in the presence of ultrasound. It was 
found that the crystalline structure and morphology of the 
resulting nano-HAP powders was dependent upon the power 
of the ultrasonic irradiation source and the subsequent thermal 
treatment used. It was evident that the presence of ultrasound 
in the synthesis process promoted the chemical reactions and 
physical effects that subsequently produced the ultrafine nano-
HAP powders after thermal treatment. The thermal influence 
on the formation of ultrafine nano-HAP powders was inves-
tigated using two thermal treatment processes. The first used 
a conventional tube furnace and the second used a domestic 
microwave oven. The tube furnace gave greater temperature 
control, with higher treatment temperatures giving smaller 
particle sizes, unlike the microwave oven treatment which did 
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not show any particle size dependence over the range of power 
settings. Both thermal treatments, in conjunction with the 
ultrasound-assisted synthesis process, produced nano-HAP 
powders with the same crystalline structure and morphology. 
The only difference arises in the size of the particles produced 
by the respective thermal treatment processes.
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